Page last updated: 2024-11-05

nitrapyrin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Nitrapyrin, also known as 2-chloro-6-(trichloromethyl)pyridine, is a widely used agricultural chemical. It is a nitrification inhibitor, meaning it prevents the conversion of ammonium to nitrate in the soil. This is important because nitrate is more susceptible to leaching than ammonium, which can lead to nitrogen loss and environmental pollution. Nitrapyrin is also used to reduce the amount of nitrogen oxide emissions from agricultural soils. The compound is synthesized through a multi-step process, beginning with the reaction of pyridine with chloral hydrate to form 2-chloro-6-(trichloromethyl)pyridine. Nitrapyrin has been shown to have several benefits, including increased nitrogen use efficiency in crops, reduced nitrogen leaching, and decreased nitrogen oxide emissions. However, there are also some concerns about the environmental and health effects of nitrapyrin. Some studies have shown that nitrapyrin can have negative impacts on soil microbial communities and can also be toxic to aquatic organisms. For these reasons, research continues to investigate the potential impacts of nitrapyrin on the environment and human health.'

Cross-References

ID SourceID
PubMed CID16004
CHEMBL ID1557091
CHEBI ID81935
SCHEMBL ID41442
MeSH IDM0068407

Synonyms (62)

Synonym
MLS002152872
smr000777845
n-serve
pyridine, 2-chloro-6-(trichloromethyl)-
NCGC00091152-01
1929-82-4
2-chloro-6-(trichloromethyl)pyridine
2-chloro-6-trichloromethyl pyridine
einecs 217-682-2
brn 1618997
ccris 4599
caswell no. 217
epa pesticide chemical code 069203
dowco-163
n-serve nitrogen stabilizer
nitrapyrine [iso-french]
nitrapyrin [ansi:bsi:iso]
NCGC00091152-02
nitrapyrin ,
NCGC00091152-03
alpha,alpha,alpha,6-tetrachloro-2-picoline
2-chloro-6-(trichloromethyl)pyridine, >=98%
AKOS000267961
STK843145
EN300-93027
A4252
NCGC00091152-04
NCGC00091152-05
2-chloro-6-trichloromethylpyridine
C18751
5-20-05-00500 (beilstein handbook reference)
nitrapyrine
unii-8pce86u01w
8pce86u01w ,
ec 217-682-2
tox21_202036
dtxcid504216
dtxsid0024216 ,
NCGC00254819-01
NCGC00259585-01
cas-1929-82-4
tox21_300916
FT-0633921
AM84664
SCHEMBL41442
CHEMBL1557091
chebi:81935 ,
nitrapyrin [mi]
nitrapyrin [iso]
2-chloro-6-trichloromethylpyridin
2 -chloro-6-(trichloromethyl)pyridine
6-chloro-2-trichloromethyl pyridine
2-chloro-6(trichloromethyl)pyridine
Q-101453
CS-W019363
AC-23339
2-picoline, .alpha.,.alpha.,.alpha.,6-tetrachloro-
2-chloro-6-(trichloromethyl)pyridine, analytical reference material
nitrapyrin, pestanal(r), analytical standard
AS-15459
Q1993935
Z56756147

Research Excerpts

Overview

Nitrapyrin is a specific inhibitor of, and is reduced by, the ammonia monoxygenase (AMO)

ExcerptReferenceRelevance
"Nitrapyrin is a specific inhibitor of, and is reduced by, the ammonia monoxygenase (AMO) [Bédard, C."( Evidence for an iron center in the ammonia monooxygenase from Nitrosomonas europaea.
Arciero, DM; DiSpirito, AA; Hooper, AB; Zahn, JA, 1996
)
1.02

Effects

ExcerptReferenceRelevance
"Nitrapyrin has been registered as a nitrogen stabilizer in the United States for many years based on a robust set of regulatory data. "( Nitrapyrin: a scientific advisory group review of the mode of action and carcinogenicity in B6C3F1 mice.
Butterworth, BE; Eisenbrandt, DL; Golllapudi, BB; Hardisty, JF; McConnell, EE; Seely, JC; Stebbins, KE; Swenberg, JA; Williams, GM; Yano, BL, 2008
)
3.23

Compound-Compound Interactions

ExcerptReferenceRelevance
" However, there are few case studies about reduced N application combined with double inhibitors (DIs, NI plus UI), especially under drip irrigation systems."( A 2-year study of the impact of reduced nitrogen application combined with double inhibitors on soil nitrogen transformation and wheat productivity under drip irrigation.
Chu, G; Hu, B; Li, J; Shah, JA; Tao, R, 2021
)
0.62
"Cutting the N application rate by 20% combined with NBPT and nitrapyrin could provide a sustainable fertilization strategy for wheat production under drip irrigation."( A 2-year study of the impact of reduced nitrogen application combined with double inhibitors on soil nitrogen transformation and wheat productivity under drip irrigation.
Chu, G; Hu, B; Li, J; Shah, JA; Tao, R, 2021
)
0.86
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
nitrification inhibitorAny inhibitor added to nitrogen fertilizers which can reduce the rate at which ammonium is converted to nitrate. Under appropriate conditions, this can help reduce nitrogen losses through denitrification and leaching.
antibacterial agentA substance (or active part thereof) that kills or slows the growth of bacteria.
agrochemicalAn agrochemical is a substance that is used in agriculture or horticulture.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
chloropyridineCompounds containing a pyridine nucleus substituted with one or more chlorine atoms.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (3)

PathwayProteinsCompounds
ammonia oxidation IV (autotrophic ammonia oxidizers)724
ammonia oxidation I (aerobic)924
nitrifier denitrification1425

Protein Targets (26)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency50.11870.003245.467312,589.2998AID2517
GLI family zinc finger 3Homo sapiens (human)Potency60.63360.000714.592883.7951AID1259369
AR proteinHomo sapiens (human)Potency63.09570.000221.22318,912.5098AID588515
thyroid stimulating hormone receptorHomo sapiens (human)Potency1.00000.001318.074339.8107AID926; AID938
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency9.68850.001530.607315,848.9004AID1224841
estrogen nuclear receptor alphaHomo sapiens (human)Potency0.48970.000229.305416,493.5996AID743075
aryl hydrocarbon receptorHomo sapiens (human)Potency48.51970.000723.06741,258.9301AID743085; AID743122
thyroid stimulating hormone receptorHomo sapiens (human)Potency54.03970.001628.015177.1139AID1259385
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency0.05620.010039.53711,122.0200AID588545
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency12.58930.031610.279239.8107AID884; AID885
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
GABA theta subunitRattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Ceullar Components (1)

Processvia Protein(s)Taxonomy
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Research

Studies (31)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (19.35)18.7374
1990's7 (22.58)18.2507
2000's5 (16.13)29.6817
2010's6 (19.35)24.3611
2020's7 (22.58)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 37.83

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index37.83 (24.57)
Research Supply Index3.61 (2.92)
Research Growth Index4.91 (4.65)
Search Engine Demand Index50.99 (26.88)
Search Engine Supply Index2.04 (0.95)

This Compound (37.83)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (5.56%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other34 (94.44%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]